W
WAVEMAN · COMPANY
GEHC · Ge Healthcare Technologies Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

GEHC

GE HealthCare Technologies Inc.
MEDICAL DEVICES · X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS · CIK 0001932393
CLUSTER · 8 INSIDERSC-SUITE BUYING · 3☆ WATCH
INSIDER NET · 180D
$6.4M
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
8
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
542
13F, latest reported quarter
REVENUE GROWTH
+4.8%
XBRL, annual
NET MARGIN
10.1%
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net +$6.4M over 180 days
more than 97% of Medical Devices
CONGRESS
no member of Congress has reported trading it
FUNDS
542 funds added or opened last quarter
more than 92% of Medical Devices
REVENUE
+4.8% year over year
below 60% of Medical Devices
MARGIN
10.1% net margin
more than 77% of Medical Devices
BUYBACKS
$100.0M repurchased, FY to 2026-03-31
more than 60% of Medical Devices
SHORT
4.3% of shares outstanding short · 2.9 days to cover · settled 2026-07-31
more than 57% of Medical Devices
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
8 insiders independently bought a net $6.4M — no planned sales are queued against it.
542 funds added or opened positions in the latest 13F quarter, of 1,229 holders.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN -2.4%
-2.4%12M
-17%-3%+10%+23%2025-092025-102025-122026-032026-052026-072026-09 2026-05-06 · CULP H LAWRENCE JR bought $5.0M2026-05-22 · Lobo Kevin bought $641.8K2026-04-30 · Arduini Peter J bought $249.8K2026-05-01 · SACCARO JAMES bought $200.6K2026-04-30 · Jimenez Frank R bought $105.8K2026-05-12 · Hochman Rodney F bought $100.4K2026-05-08 · Yang Watkin Phoebe L. bought $63.0K2026-05-06 · Stromberg William J bought $61.7K
INSIDER BUY
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
8 insiders reported buying shares.
The record shows a net $6.4M bought by insiders over 180 days, 542 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
TMOPENROKBLFSMTDSIBNWRBYISRGTXGDXCMEWTMDX
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, GE HealthCare Technologies Inc. insiders bought a net $6.4M of stock across 23 Form 4 purchases and sales, with 8 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE
Lobo Kevin
Director
BUY
2026-05-22
10,000.0
$641.8K
Hochman Rodney F
Director
BUY
2026-05-12
1,618.0
$100.4K
Yang Watkin Phoebe L.
Director
BUY
2026-05-08
1,000.0
$63.0K
CULP H LAWRENCE JR
Director
BUY
2026-05-06
80,805.0
$5.0M
Stromberg William J
Director
BUY
2026-05-06
1,000.0
$61.7K
23 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 18 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
Dodge & Cox
37,864,164.0 sh
$2.4B
BlackRock, Inc.
37,467,843.0 sh
$2.4B
VANGUARD CAPITAL MANAGEMENT LLC
29,724,359.0 sh
$1.9B
STATE STREET CORP
20,861,566.0 sh
$1.3B
VANGUARD PORTFOLIO MANAGEMENT LLC
20,275,526.0 sh
$1.3B
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Invesco S&P Spin-Off ETF
$8.4M POSITION · AS OF 2026-04-30
5.7%
Global X HealthTech ETF
$1.9M POSITION · AS OF 2026-02-28
5.2%
iShares U.S. Medical Devices ETF
$139.6M POSITION · AS OF 2026-03-31
4.4%
Capital Group U.S. Large Value ETF
$3.1M POSITION · AS OF 2026-02-28
3.5%
AMG River Road Focused Absolute Value Fund
$1.5M POSITION · AS OF 2026-04-30
3.1%
Touchstone Strategic Trust-Touchstone Value Fund
$17.3M POSITION · AS OF 2026-03-31
3.1%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Executive pay vs shareholder return
DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself
FY
CEO TOTAL
ACTUALLY PAID
OTHER NEOs AVG
TSR
PEER TSR
2025
$18.6M
$19.6M
$5.7M
+36%
+22%
2024
$19.5M
$13.4M
$5.2M
+30%
+14%
2023
$24.5M
$29.8M
$9.1M
+28%
+1%
2022
$10.5M
$7.3M
$4.7M
—
—
TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$20.6B$19.7B$19.6B$18.3B
GROSS PROFIT$8.2B$8.2B$7.9B$7.2B
OPERATING INCOME$2.8B$2.6B$2.4B$2.5B
NET INCOME$2.1B$2.0B$1.6B$1.9B
EPS (DILUTED)4.554.343.034.22
CASH$4.5B$2.9B$2.5B$1.4B
LONG-TERM DEBT$9.5B$7.4B$8.4B$8.2B
BUYBACKS$200.0M$0$0—
DIVIDENDS PAID$64.0M$55.0M$41.0M$0
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
PRODUCT
DeskBacktester CompaniesAccount
SUPPORT
FAQMethodology Contact
LEGAL
TermsPrivacy Accessibility
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →